Yoshiko Furukawa < Yoshikuni Mizuno < Yoshimi Otani

Facettes :

List of bibliographic references indexed by Yoshikuni Mizuno

Number of relevant bibliographic references: 16.

Ident.	Authors (with country if any)	Title
000255 (2011)	Thomas Gasser [Allemagne] ; John Hardy [Royaume-Uni] ; Yoshikuni Mizuno [Japon]	Milestones in PD genetics
000567 (2010)	Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]	Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study
000568 (2010)	Manabu Funayama [Japon] ; Hiroyuki Tomiyama [Japon] ; Ruey-Meei Wu [Taïwan] ; Kotaro Ogaki [Japon] ; Hiroyo Yoshino [Japon] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon]	Rapid screening of ATP13A2 variant with high‐resolution melting analysis
000569 (2010)	Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]	Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000732 (2010)	Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]	Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000A91 (2009)	Kenya Nishioka [Japon, États-Unis] ; Owen A. Ross [États-Unis] ; Kenji Ishii [Japon] ; Jennifer M. Kachergus [États-Unis] ; Kiichi Ishiwata [Japon] ; Mayumi Kitagawa [Japon] ; Satoshi Kono [Japon] ; Tomokazu Obi [Japon] ; Koichi Mizoguchi [Japon] ; Yuichi Inoue [Japon] ; Hisamasa Imai [Japon] ; Masashi Takanashi [Japon] ; Yoshikuni Mizuno [Japon] ; Matthew J. Farrer [États-Unis] ; Nobutaka Hattori [Japon]	Expanding the clinical phenotype of SNCA duplication carriers
001075 (2007)	Bruno Dubois [France] ; David Burn [Royaume-Uni] ; Christopher Goetz [États-Unis] ; Dag Aarsland [Norvège] ; Richard G. Brown [Royaume-Uni] ; Gerald A. Broe [Australie] ; Dennis Dickson [États-Unis] ; Charles Duyckaerts [France] ; Jefferey Cummings [États-Unis] ; Serge Gauthier [Canada] ; Amos Korczyn [Israël] ; Andrew Lees (neurologue) [Royaume-Uni] ; Richard Levy [France] ; Irene Litvan [États-Unis] ; Yoshikuni Mizuno [Japon] ; Ian G. Mckeith [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Eduardo Tolosa [Espagne] ; Murat Emre [Turquie]	Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force
001210 (2006)	Shin-Ichiro Kubo [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon]	Recessive Parkinson's disease
001222 (2006)	Kenichi Sato [Japon] ; Taku Hatano [Japon] ; Kazuo Yamashiro [Japon] ; Maki Kagohashi [Japon] ; Kenya Nishioka [Japon] ; Nana Izawa [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Hideo Mori [Japon] ; Yoshikuni Mizuno [Japon]	Prognosis of Parkinson's disease: Time to stage III, IV, V, and to motor fluctuations
001338 (2006)	Kenya Nishioka [Japon] ; Shin Hayashi [Japon] ; Matthew J. Farrer [États-Unis] ; Andrew B. Singleton [États-Unis] ; Hiroyo Yoshino ; Hisamasa Imai [Japon] ; Toshiaki Kitami [Japon] ; Kenichi Sato [Japon] ; Ryu Kuroda ; Hiroyuki Tomiyama [Japon] ; Koichi Mizoguchi ; Miho Murata [Japon] ; Tatsushi Toda [Japon] ; Issei Imoto [Japon] ; Johji Inazawa [Japon] ; Yoshikuni Mizuno [Japon] ; Nobutaka Hattori [Japon]	Clinical heterogeneity of α‐synuclein gene duplication in Parkinson's disease
001437 (2005)	Katsumi Tsuchiya [Japon] ; Hisao Tajima [Japon] ; Toyoyasu Kuwae [Japon] ; Takao Takeshima [Japon] ; Toshiya Nakano [Japon] ; Masaharu Tanaka [Japon] ; Katsuyoshi Sunaga [Japon] ; Yoko Fukuhara [Japon] ; Kenji Nakashima [Japon] ; Eisaku Ohama [Japon] ; Hideki Mochizuki [Japon] ; Yoshikuni Mizuno [Japon] ; Nobuo Katsube [Japon] ; Ryoichi Ishitani [Japon]	Pro‐apoptotic protein glyceraldehyde‐3‐phosphate dehydrogenase promotes the formation of Lewy body‐like inclusions
001532 (2005)	Darren J. Moore ; Li Zhang ; Juan Troncoso ; Michael K. Lee ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon] ; Ted M. Dawson ; Valina L. Dawson [États-Unis]	Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress
001542 (2005)	Carolyn F. Orr ; Dominic B. Rowe ; Yoshikuni Mizuno [Japon] ; Hideo Mori [Japon] ; Glenda M. Halliday	A possible role for humoral immunity in the pathogenesis of Parkinson's disease
001761 (2003)	Hideo Mori [Japon] ; Nobutaka Hattori [Japon] ; Yoshikuni Mizuno [Japon]	Genotype–phenotype correlation: Familial Parkinson disease
001E91 (1998)	Nobutaka Hattori [Japon] ; Hiroyo Yoshino [Japon] ; Masashi Tanaka [Japon] ; Hiroshi Suzuki [Japon] ; Yoshikuni Mizuno [Japon]	Genotype in the 24-kDa Subunit Gene (NDUFV2) of Mitochondrial Complex I and Susceptibility to Parkinson Disease
002A15 (1985)	Yasuo Toyokura ; Yoshikuni Mizuno ; Masao Kase ; Itsuro Sobue ; Yoshigoro Kuroiwa ; Hirotaro Narabayashi ; Masanori Uono ; Takao Nakanishi ; Masakuni Kameyama ; Hitoshi Ito ; Yasuo Shimada ; Makoto Iwata	Effects of bromocriptine on Parkinsonism A nation‐wide collaborative double‐blind study

---

List of associated KwdEn.i

Nombre de documents	Descripteur
11	Parkinson's disease
2	dopamine agonist
2	mitochondria
2	treatment
1	24-kDa subunit
1	Bromocriptine
1	DJ‐1
1	DNA polymorphisms
1	Hoehn & Yahr stage
1	IgG = immunoglobulin G
1	IgM = immunoglobulin M
1	Japan
1	Lewy bodies
1	PARK9
1	PD dementia
1	PET
1	PINK1
1	Park 1
1	Park 2
1	Parkin
1	Parkinson disease
1	Parkinsonism
1	SN = substantia nigra pars compacta
1	SNCA duplication
1	clinical trial
1	coaggregation
1	complex I
1	delayed‐start
1	dementia
1	diagnostic criteria
1	double‐blind study
1	executive functions
1	familial Parkinson disease
1	gene risk factor
1	genetic predisposition
1	genetic risk factors
1	genetics
1	humoral immunity
1	levodopa
1	lightscanner
1	microglia
1	mortality
1	neuropathology
1	neuroprotection
1	oxidative stress
1	parkin
1	pramipexole
1	pramipexole extended release
1	pramipexole‐extended release
1	prognosis
1	pro‐apoptotic GAPDH
1	recessive Parkinson's disease
1	reduced penetrance
1	switch trial
1	task force
1	ubiquitin–proteasome system
1	wild‐type α‐synuclein
1	α‐synuclein

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Yoshikuni Mizuno" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Yoshikuni Mizuno" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Yoshikuni Mizuno
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024